Hemosol starts artificial blood trials for patients undergoing heart bypass surgery
This article was originally published in Clinica
Executive Summary
Hemosol is to begin clinical trials in Canada of its oxygen-carrying artificial blood, Hemolink, in patients undergoing coronary artery bypass surgery (CABG).